XML 62 R43.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Compensation (Tables)
12 Months Ended
Oct. 03, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The following table summarizes the share-based compensation expense and related information for Time-Based Options ("TBOs"), RSUs, PSUs and other awards recorded within "Selling and general corporate expenses" on the Consolidated Statements of Income (in millions):
Fiscal Year Ended
October 3, 2025September 27, 2024September 29, 2023
TBOs
$9.3 $9.7 $14.3 
RSUs31.5 32.5 43.5 
PSUs13.1 14.9 9.7 
Other(1)
4.7 5.5 8.8 
$58.6 $62.6 $76.3 
Taxes related to share-based compensation$9.5 $10.2 $13.0 
Cash Received from Option Exercises
43.0 36.6 45.6 
(1)
Consists of retention-based options, deferred stock units, employee stock purchase plans and stock appreciation rights. Each of these components are individually insignificant to the share-based compensation expense for fiscal years ending October 3, 2025, September 27, 2024 and September 29, 2023.
Schedule of Unrecognized Compensation Cost, Nonvested Awards
The below table summarizes the unrecognized compensation expense as of October 3, 2025 related to non-vested awards and the weighted-average period they are expected to be recognized:
Unrecognized Compensation Expense
(in millions)
Weighted-Average Period
(Years)
TBOs$20.4 2.62
RSUs69.4 2.56
PSU29.6 1.80
Total$119.4 
Schedule of Stock Option Valuation Assumptions
The table below presents the weighted average assumptions and related valuations for TBOs:
Fiscal Year Ended
October 3, 2025September 27, 2024September 29, 2023
Expected volatility43%43%42%
Expected dividend yield
1.04% - 1.17%
1.19% - 1.35%
1.39% - 1.64%
Expected life (in years)(1)
6.256.256.25
Risk-free interest rate
4.03% - 4.48%
3.99% - 4.41%
3.65% - 4.28%
Weighted-average grant-date fair value$17.62$12.04$11.76
(1)
The expected life represents the period of time that options granted are expected to be outstanding and is calculated using the simplified method as permitted under Securities and Exchange Commission rules and regulations due to the method providing a reasonable estimate in comparison to actual experience. The simplified method uses the midpoint between an option's vesting date and contractual term.
Fiscal Year Ended
October 3, 2025September 27, 2024September 29, 2023
Total intrinsic value exercised (in millions)$21.0 $15.3 $12.0 
Total fair value that vested (in millions)10.2 10.6 15.7 
Fiscal Year Ended
October 3, 2025September 27, 2024September 29, 2023
Total fair value that vested (in millions)$36.9 $37.9 $57.1 
Schedule of Options Activity
A summary of TBO activity is presented below:
Options
Shares
(in thousands)
Weighted-Average Exercise Price
Aggregate Intrinsic Value
(in thousands)
Weighted-Average Remaining Term
(Years)
Outstanding at September 27, 20247,907 $26.14 
Granted771 $40.25 
Exercised(1,560)$26.02 
Forfeited and expired(80)$30.20 
Outstanding at October 3, 20257,038 $27.67 $80,691 5.8
Exercisable at October 3, 20255,063 $25.58 $67,967 4.8
Expected to vest at October 3, 20251,763 $32.89 $11,624 8.3
Schedule of Restricted Stock Units Activity
Restricted Stock Units
Units
(in thousands)
Weighted Average Grant-Date Fair Value
Outstanding at September 27, 20243,256$28.32 
Granted1,249$40.23 
Vested(1,346)$27.46 
Forfeited(226)$32.88 
Outstanding at October 3, 20252,933 $33.49 
Schedule of Performance Stock Units
Performance Stock Units
Units
(in thousands)
Weighted Average Grant-Date Fair Value
Outstanding at September 27, 20241,798$30.56 
Granted513$41.61 
Vested(698)$28.82 
Forfeited(21)$35.73 
Outstanding at October 3, 20251,592 $36.51